Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term follow-up in a monoinstitutional experience

Orazio Caffo,Giovanni Fellin,U. Graffer,Salvatore Mussari,Alessia Caldara,V. Murgia,F. Valduga,Luigi Tomio,Enzo Galligioni

Cisplatin (C) and gemcitabine (G) chemotherapy with concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients: Clinical outcome and long-term follow-up in a monoinstitutional experience

2009

Orazio Caffo
Giovanni Fellin
U. Graffer
Salvatore Mussari
Alessia Caldara
V. Murgia
F. Valduga
Luigi Tomio
Enzo Galligioni

e16081 Background: C and G have synergistic activity when used in combination and are both potent radiosensitizers. In a dose finding trial, conducted in our hospital on ITBC patients using C and G...

Keywords:

Medicine
conservative treatment
long term follow up
Bladder cancer
Oncology
Gemcitabine
Chemotherapy
Cisplatin
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations